Ipamorelin

Accelerating

Ipamorelin appears in 66 indexed publications going back to 1998, including 11 in the past twelve months. 2 registered trials appear on ClinicalTrials.gov.

Indexed publications

Past 12 months, against 0 the year before

Registered clinical trials

6,228

Monthly readers on Wikipedia, up 1%

Research Activity

Publication history

How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.

20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
2015	2
2016	2
2017	2
2018	3
2019	1
2020	2
2021	0
2022	0
2023	0
2024	2
2025	1
2026	10

Public Attention

Who is looking it up

Monthly readers of the Ipamorelin article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.

2025-082026-07

Clinical Trials

The registered pipeline

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase distribution across the most recently updated registered trials.

Completed·Phase 2
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
Helsinn Therapeutics (U.S.), Inc · completed 2009-12
Completed·Phase 2
Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function
Helsinn Therapeutics (U.S.), Inc · completed 2013-06

References

Most recent work

The newest indexed records mentioning Ipamorelin, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.

2026-03-25·The Journal of sports medicine and physical fitness
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review
Coutinho LFD, DE Oliveira Neves LF, Camilo RP. et al.
2026-05-20·JBJS reviews
Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications
Villegas Meza AD, Nocek M, Mitchell BC et al.
2026-04-27·International journal of molecular sciences
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives
Renke G, Chinellato L. et al.
2026-04-12·Sports medicine (Auckland, N.Z.)
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Mendias CL, Awan TM. et al.
2026-06-18·Frontiers in endocrinology
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Dominikowski A, Rękoś Z, Olejarz M et al.
2026-04-07·Frontiers in aging
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Mavrych V, Shypilova I, Bolgova O. et al.
2026-01-02·Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Rahman OF, Lee SJ, Seeds WA. et al.
2026-01-01·The American journal of sports medicine
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
Mayfield CK, Bolia IK, Feingold CL et al.

Sources

Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-08-02.